Postmenopausal Vulvovaginal Atrophy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-10-18
Clinical Trial Update: A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy [Phase 3]
Phase 3 clinical study of INTRAROSA (prasterone) vaginal inserts for postmenopausal vulvovaginal atrophy has completed.